Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Proton Bio logo — Empowering breakthroughs in Cell and Gene Therapy with compr...

Proton Bio

Empowering breakthroughs in Cell and Gene Therapy with comprehensive development and manufacturing solutions.

Founded 2018 201-500 employees Series B Total: $520.00M Biopharma, Biotechnology

General Information

Company Name Proton Bio
Founded Year 2018
Employees 201-500
Industries Biopharma, Biotechnology
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Proton Bio. To contact Proton Bio, visit portonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Proton Bio compare?

A PDF of Proton Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Proton Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Proton Bio

Proton Bio, a leader in Cell and Gene Therapy (CGT) solutions, is revolutionizing the biopharma and biotechnology industries with its comprehensive development and manufacturing services. Since its establishment in 2018, the company has been empowering breakthroughs in CGT, offering a range of services including process development, analytical development, GMP manufacturing, and testing at every stage from pre-clinical to commercialization. The recent CNY520.00M Series B investment on 19 August 2022 from an impressive lineup of investors including Hillhouse Investment, Huatai Health Fund, Huimei Capital, Advanced Manufacturing Industry Investment Fund, China Merchants Venture Capital, China Merchants Securities, Fosun Pharma, Huatai Zijin Investment further underscores Proton Bio's potential for growth and impact in the industry. With its mission to meet the evolving demands of the CGT sector, Proton Bio is poised for significant advancements and market influence.

Business keywords: Cell Therapy, Gene Therapy, CDMO, Process Development, Analytical Development, GMP Manufacturing, Testing Services, Biopharmaceuticals, Therapeutic Products, Clinical Stage, Pre-clinical Stage, Commercial Stage, CDMO Services, Holistic Solutions, Comprehensive Services

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY520.00M 8
Hillhouse Investment Huatai Zijin Investment
Hillhouse Investment, Huatai Zijin Investment +6
19 Aug 2022

Proton Bio Alternatives & Competitors

Proton Bio vs
Andelyn Biosciences
Andelyn Biosciences United States

Accelerating the development and manufacturing of innovative therapies to bring more treatments to m...

Grant
214 employees
Biopharma, Biotechnology
Proton Bio vs
BioInno
BioInno

Empowering global biopharma with world-class cell culture and GMP production services.

Series A
Biopharma, Biotechnology
Proton Bio vs
JOINN Biologics US Inc.
JOINN Biologics US Inc. United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology

FAQ About Proton Bio

Empowering breakthroughs in Cell and Gene Therapy with comprehensive development and manufacturing solutions.
Proton Bio was founded in 2018.
Proton Bio operates in Biopharma and Biotechnology. Its work centres on Cell Therapy, Gene Therapy, CDMO and Process Development.
Proton Bio has approximately 201-500 employees.
Proton Bio has completed 1 funding round, raising a total of $520.00M. The latest funding stage is Series B.
Top alternatives and competitors to Proton Bio include Andelyn Biosciences, BioInno, JOINN Biologics US Inc., Kincell Bio, CMAB Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proton Bio and Andelyn Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Proton Bio, https://bouncewatch.com/company/proton-bio, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes